PROCYTOX
As listed in the register: PROCYTOX
2000 mg · powder for solution
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Cyclophosphamide
- Made by
- Baxter Corporation
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Cyclophosphamide). It describes the substance, not this exact product.
The mechanism of action has not been fully characterized.
However, cross-linking of tumor cell DNA may be involved.
Cyclophosphamide is metabolized by cytochrome P450s including CYP2A6, 2B6, 3A, 2C9, and 2C19.
Cyclophosphamide and its metabolites are eliminated by hepatic and renal pathways.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-03-12
Safety of the active substance
From the US prescribing label for the same active substance (Cyclophosphamide). It describes the substance, not this exact product.
- Hypersensitivity Cyclophosphamide for Injection is contraindicated in patients who have a history of severe hypersensitivity reactions to cyclophosphamide, any of its metabolites, or to other components of the product.
- Anaphylactic reactions including death have been reported with cyclophosphamide.
- Cross-sensitivity with other alkylating agents can occur.
- Urinary Outflow Obstruction Cyclophosphamide Injection is contraindicated in patients with urinary outflow obstruction [see Warnings and Precautions ( 5.2 )].
The most common adverse reactions were neutropenia, febrile neutropenia, fever, alopecia, nausea, vomiting, and diarrhea.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
SpainNo exact match for this strength and form
FranceNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
SwitzerlandNo exact match for this strength and form
Details
| Made by | Baxter Corporation |
|---|---|
| Active substance | Cyclophosphamide |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 2000 mg |
| Form | powder for solution |
| Classification | L01AA01 · Cancer treatments and immune-system medicines |
| Route | intravenous |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Marketed |
| Marketed | Yes, according to the register |
| DIN | 02241800 |
| DPD drug code | 65465 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Other strengths and forms
6 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.